[Antibiotic activity of P. aeruginosa against MRSA and Candida albicans]

Shigemi Kondo1, Naotake Sato, Toshihiko Yamada

  • 1Department of Clinical Pathology, Juntendo University School of Medicine.

Insights

Pseudomonas aeruginosa exhibits antibiotic activity against MRSA and Candida. This bacterial interference persists against Candida longer than against MRSA, suggesting a novel inhibitory factor.

Area of Science:

  • Microbiology
  • Bacterial Interference
  • Antimicrobial Activity

Background:

  • Bacterial interference by Pseudomonas aeruginosa (Bacillus pyocyaneus) was noted over a century ago.
  • Recent studies on P. aeruginosa's interference with pathogens are limited.
  • Methicillin-resistant Staphylococcus aureus (MRSA) and Candida species are significant clinical threats.

Purpose of the Study:

  • To investigate the anti-MRSA and anti-Candida activities of clinical P. aeruginosa isolates.
  • To evaluate the stability and factors influencing this antibiotic activity.

Main Methods:

  • Tested 34 clinical P. aeruginosa strains for antimicrobial activity using the reversed agar plate method.
  • Assessed activity after 24 and 48-hour incubations.
  • Evaluated the impact of 5% sheep blood on agar plates.

Main Results:

  • Strong anti-MRSA and anti-Candida activity observed at 24 hours.
  • Anti-MRSA activity decreased significantly by 48 hours, while anti-Candida activity persisted.
  • Inhibitory activity correlated with dye production; non-dye-producing strains showed sustained anti-Candida activity.
  • Persistence of anti-Candida activity, even with added blood, suggests a novel P. aeruginosa factor.

Conclusions:

  • Clinical P. aeruginosa isolates possess significant, albeit variable, antibiotic activity against MRSA and Candida.
  • Anti-Candida activity is more stable than anti-MRSA activity.
  • A potential new inhibitory factor produced by P. aeruginosa warrants further investigation.
  • Bacterial interference should be considered when choosing antibiotics for patients with P. aeruginosa colonization or infection.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...